Ted Stephens

In his new role, Ted Stephens will focus on meeting increased commercial demand of the Transoral Incisionless Fundoplication (TIF®) 2.0 procedure using EsophyX® technology, a minimally-invasive procedure for the treatment of Gastroesophageal Reflux Disease (GERD).